Industry News
The latest medical device regulatory news, clinical trials, and market insights
TÜV SÜD Webinar: Clinical Evaluation of Medical Devices Under EU MDR
TÜV SÜD training webinar on clinical evaluation requirements for medical devices under the EU MDR, covering clinical evaluation plans, literature…
Mantra Systems Webinar: Post-Market Surveillance – PMCF and Vigilance Under EU MDR
Webinar on post-market surveillance requirements under the EU MDR, focusing on Post-Market Clinical Follow-up (PMCF) studies, vigilance reporting, and periodic…
QbD Group Webinar: EU MDR Bottleneck 2026 – Strategies for Medical Device Manufacturers
With notified body capacity constraints creating bottlenecks in 2026, QbD Group experts discuss strategies for medical device manufacturers to navigate…
Device alert: Erbe Cryoprobe rupture risk
FDA MedWatch warns Erbe USA cryoprobes may rupture during activation, risking hearing loss and injuries. The agency and manufacturer urge…
Wound Dressing Device Recall: Integra Removes MediHoney and CVS Products
FDA MedWatch reports a wound dressing device recall by Integra LifeSciences after sterile barrier breaches in MediHoney and CVS Wound…
Swissmedic Introduces New Authorisation Pathway for Herbal Medicinal Products with Orphan Drug Status
What changed? Swissmedic has introduced a new authorisation pathway for herbal medicinal products with orphan drug status. This change aims…
Swissmedic Introduces Machine-to-Machine Product Registration: What You Need to Know
What is M2M Product Registration? Starting from the end of March 2026, swissdamed playground will offer Machine-to-Machine (M2M) product registration…
Swissmedic Sees 17% Rise in Illegal Medicinal Product Imports from the EU in 2025
According to a recent announcement by Swissmedic, there has been a significant increase in the number of illegal imports of…
Swissmedic Initiates Batch Recall of Verkazia Augentropfen Emulsion
Swissmedic Initiates Batch Recall of Verkazia Augentropfen Emulsion Swissmedic, the Swiss agency for therapeutic products, has initiated a batch recall…
Swissmedic Clears Record Number of Human Medicinal Products with New Active Substances in 2025
On February 17, 2026, Swissmedic announced a milestone in the authorization of human medicinal products with new active substances and…
Swissmedic Issues Important Update on Cytosar (Cytarabinum): What You Need to Know
As of February 18, 2026, Swissmedic has released a crucial update regarding Cytosar (Cytarabinum), a medication used in the treatment…
RSNA 2026 Annual Meeting to Advance Radiology and Medical Imaging Technology
RSNA 2026 Annual Meeting takes place November 29 – December 3, 2026 in Chicago. The Radiological Society of North America…